SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027026
Filing Date
2023-06-08
Accepted
2023-06-08 16:31:08
Documents
12
Period of Report
2023-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K beam-20230606.htm   iXBRL 8-K 99917
  Complete submission text file 0000950170-23-027026.txt   213962

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20230606_pre.xml EX-101.PRE 9441
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20230606.xsd EX-101.SCH 2451
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20230606_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT beam-20230606_htm.xml XML 4518
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 231002363
SIC: 2836 Biological Products, (No Diagnostic Substances)